ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2426

Distinct Clinical Characteristics of Anti-Ro/SSA Negative Primary Sjögren’s Syndrome: Data from a Cohort for Sjögren’s Syndrome in Korea

Youngjae Park1, Jennifer Lee 1, Jung Hee Koh 2, Yoon-Kyoung Sung 3, Shin-Seok Lee 4, Jung Yoon Choe 5, Seung-Cheol Shim 6, Ji-Min Kim 7, Seong-Ryul Kwon 8, Hyun-Ok Kim 9, So-Hyang Chung 10, Wan-Uk Kim 1, Sung-Hwan Park 1 and Seung-Ki Kwok 1, 1Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, 2Division of Rheumatology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, the Catholic University of Korea, Bucheon, Republic of Korea, 3Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 4Department of Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, Republic of Korea, 5Division of Rheumatology, Daegu Catholic University Medical Center, Daegu, Republic of Korea, 6Division of Rheumatology, Department of Internal Medicine, School of Medicine, Chungnam National University, Chungnam National University Hospital, Daejeon, Republic of Korea, 7Division of Rheumatology, Department of Internal Medicine, Keimyung University Dongsan Medical Centre, Daegu, Republic of Korea, 8Inha University Hospital, Incheon, Republic of Korea, 9Division of Rheumatology, Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea, 10Department of Ophthalmology and Visual Science, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: autoantibodies and salivary gland, Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Sjögrenʼs Syndrome – Basic & Clinical Science Poster I

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: To investigate clinical characteristics of patients with primary Sjögren’s syndrome (SS) who were negative for anti-Ro/SSA antibody but positive for minor salivary gland biopsy (MSGB) compared to patients who presented positivity for anti-Ro/SSA antibody.

Methods: Data of 355 patients from the Korean Initiative of primary Sjögren’s Syndrome (KISS), a nationwide prospective cohort for primary SS in Korea, were analyzed. All patients fulfilled 2016 American College of Rheumatology/European League Against Rheumatism (EULAR) classification criteria. Of these patients, 326 were positive for anti-Ro/SSA antibody and 29 were antibody-negative, although they had positive findings in MSGB. Various clinical features including all kinds of tests for evaluating secretory function, disease-related clinical indices and serological values available in the cohort were compared between the two groups.

Results: The anti-Ro/SSA negative group showed less rheumatoid factor positivity (p < 0.001), leucopenia (p = 0.003), hypergammaglobulinemia (p < 0.001), lower serum β2-microglobulin level (p = 0.034), more anti-centromere antibody positivity (p < 0.001), higher score in dryness domain of EULAR SS patient reported index (p = 0.048) and more positivity for peripheral nervous system domain in EULAR SS disease activity index and loss of teeth in SS disease damage index (p = 0.021 and 0.041, respectively) than patients who were positive for anti-Ro/SSA antibody.

Conclusion: Primary SS patients who are negative for anti-Ro/SSA antibody have different clinical characteristics compared to patients who are positive for such antibody in Korea. Therefore, clinicians should consider MSGB in patients with suspicious symptoms who are anti-Ro/SSA negative.

Clinical features of 355 enrolled patients with primary Sjogren’s syndrome

Clinical indices for disease-related systemic activity, extraglandular manifestations and long-term damage

Serological features


Disclosure: Y. Park, None; J. Lee, None; J. Koh, None; Y. Sung, BMS, Eisai, JW pharmaceuticals, Pfizer; S. Lee, None; J. Choe, None; S. Shim, None; J. Kim, None; S. Kwon, None; H. Kim, None; S. Chung, None; W. Kim, None; S. Park, None; S. Kwok, None.

To cite this abstract in AMA style:

Park Y, Lee J, Koh J, Sung Y, Lee S, Choe J, Shim S, Kim J, Kwon S, Kim H, Chung S, Kim W, Park S, Kwok S. Distinct Clinical Characteristics of Anti-Ro/SSA Negative Primary Sjögren’s Syndrome: Data from a Cohort for Sjögren’s Syndrome in Korea [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/distinct-clinical-characteristics-of-anti-ro-ssa-negative-primary-sjogrens-syndrome-data-from-a-cohort-for-sjogrens-syndrome-in-korea/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/distinct-clinical-characteristics-of-anti-ro-ssa-negative-primary-sjogrens-syndrome-data-from-a-cohort-for-sjogrens-syndrome-in-korea/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology